American Beacon Advisors’s Pfizer PFE Stock Holding History

American Beacon Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,372	Closed	-$99K	–	72
2018 Q3	$99K	Buy	2,372 +189	+9%	+$7.28K	0.67%	56
2018 Q2	$75K	Sell	2,183 -3,494	-62%	-$119K	0.69%	65
2018 Q1	$191K	Hold	5,677	–	–	2.03%	11
2017 Q4	$195K	Buy	5,677 +602	+12%	+$20.5K	2.09%	8
2017 Q3	$172K	Buy	5,075 +3,057	+151%	+$98.3K	2.05%	6
2017 Q2	$64K	Hold	2,018	–	–	0.82%	69
2017 Q1	$65.5K	Buy	+2,018	New	+$63.6K	0.86%	64

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

American Beacon Advisors's PFE Position: Q4 2018 in Review

American Beacon Advisors sold out of Pfizer (PFE) in Q4 2018, closing a stake of 2,372 shares — an estimated $99K sold.

American Beacon Advisors first reported a position in PFE in Q1 2017 and held it in 7 quarters. The position peaked at $195K in Q4 2017. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

American Beacon Advisors reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
American Beacon Advisors sold 2,372 Pfizer shares in Q4 2018, an estimated $99K.
American Beacon Advisors first reported a position in Pfizer in Q1 2017 and held it in 7 quarters.
American Beacon Advisors's Pfizer position peaked at $195K in Q4 2017.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on American Beacon Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.